Subscribe here to receive updates, including stories like these, via email. Or if you have your own blood cancer story to share, we’d love to hear from you.
Ten months after his diagnosis and having failed standard treatment, George Yiannakis is the first of potentially 12 Australians to go on the international MM24 clinical trial for AL amyloidosis.
We spoke to Dr Sidiqi about his specialising field of amyloidosis.
Daratumumab (Darzalex®) could be the first ever therapy to be approved in Australia for AL amyloidosis.
Noemi Horvath is a highly reputed consultant haematologist at Royal Adelaide Hospital who has dedicated most of her life to her work and her special interest has long been amyloidosis.
When Sue was diagnosed with a blood cancer, she found herself living through experiences she had discussed in one of her talks, This is Not the Life I Ordered.
David’s AL amyloidosis is in remission following compassionate access to daratumumab.
